12-70555053-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001109754.4(PTPRB):c.5143+107T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,326,202 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 2 hom. )
Consequence
PTPRB
NM_001109754.4 intron
NM_001109754.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.264
Publications
4 publications found
Genes affected
PTPRB (HGNC:9665): (protein tyrosine phosphatase receptor type B) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and one intracytoplasmic catalytic domain, thus belongs to receptor type PTP. The extracellular region of this PTP is composed of multiple fibronectin type_III repeats, which was shown to interact with neuronal receptor and cell adhesion molecules, such as contactin and tenascin C. This protein was also found to interact with sodium channels, and thus may regulate sodium channels by altering tyrosine phosphorylation status. The functions of the interaction partners of this protein implicate the roles of this PTP in cell adhesion, neurite growth, and neuronal differentiation. Alternate transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BS2
High AC in GnomAd4 at 169 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTPRB | NM_001109754.4 | c.5143+107T>C | intron_variant | Intron 20 of 33 | ENST00000334414.11 | NP_001103224.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTPRB | ENST00000334414.11 | c.5143+107T>C | intron_variant | Intron 20 of 33 | 1 | NM_001109754.4 | ENSP00000334928.6 |
Frequencies
GnomAD3 genomes AF: 0.00111 AC: 169AN: 152088Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
169
AN:
152088
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00124 AC: 1459AN: 1173996Hom.: 2 AF XY: 0.00126 AC XY: 737AN XY: 583594 show subpopulations
GnomAD4 exome
AF:
AC:
1459
AN:
1173996
Hom.:
AF XY:
AC XY:
737
AN XY:
583594
show subpopulations
African (AFR)
AF:
AC:
8
AN:
25950
American (AMR)
AF:
AC:
28
AN:
26804
Ashkenazi Jewish (ASJ)
AF:
AC:
37
AN:
18876
East Asian (EAS)
AF:
AC:
0
AN:
36412
South Asian (SAS)
AF:
AC:
8
AN:
64554
European-Finnish (FIN)
AF:
AC:
29
AN:
48334
Middle Eastern (MID)
AF:
AC:
5
AN:
4174
European-Non Finnish (NFE)
AF:
AC:
1285
AN:
898996
Other (OTH)
AF:
AC:
59
AN:
49896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
72
144
216
288
360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00111 AC: 169AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00129 AC XY: 96AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
169
AN:
152206
Hom.:
Cov.:
32
AF XY:
AC XY:
96
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
10
AN:
41544
American (AMR)
AF:
AC:
24
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5164
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
5
AN:
10590
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
120
AN:
68002
Other (OTH)
AF:
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.